Ingredient record · Blood pressure medicine (ARB)
Telmisartan: bans, restrictions and failed batches in India
Last checked 3 November 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Sep 2026
5 entries containing Telmisartan are on India's banned-drugs list, and 3 are banned today. 213 batches of medicines containing Telmisartan failed a government lab test between May 2019 and September 2026, from 110 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
3
Banned combinations in force
2
Other listed orders (stayed, restricted, quashed)
213
Batches failed a lab test
Sep 2026
Latest lab alert
Is it banned? Our answer pages
Not banned · spurious batches reported
Not banned · spurious batches reported
Not banned · spurious batches reported
Not banned · spurious batches reported
On the banned-drugs list
Telmisartan on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
| Drug / combination | Action | Notification | Date | Order | Status note |
|---|---|---|---|---|---|
| Telmisartan + Ramipril + HydrochlorothiazideFixed-dose combination · cardiac | Banned | S.O. 252(E) | 11 January 2019 | Other orders | One of 80 FDCs prohibited vide S.O. 180(E)-259(E) dated 11.01.2019 (CDSCO letter 22.01.2019). In force per CDSCO list as on 22.11.2021. |
| Clindamycin + TelmisartanFixed-dose combination · antibiotics | Banned | S.O. 4454(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Telmisartan + MetforminFixed-dose combination · diabetes | Banned | S.O. 4694(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Clindamycin + TelmisartanFixed-dose combination · antibiotics | Quashed | S.O. 786(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Telmisartan + MetforminFixed-dose combination · diabetes | Quashed | S.O. 1041(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Telmisartan | 144 | 67 | Sep 2026 |
| Telmisartan Amlodipine | 23 | 19 | Sep 2026 |
| Telmisartan Hydrochlorothiazide | 10 | 8 | Jul 2026 |
| Metoprolol Succinate Telmisartan | 3 | 3 | Sep 2026 |
| Telmisartan Amlodipine Besylate | 3 | 3 | Jun 2026 |
| Telmisartan Savtel | 2 | 1 | Dec 2025 |
| Telmisartan Hydrochlorothizide | 2 | 2 | Nov 2025 |
| Telmicept | 2 | 1 | Jul 2021 |
| Telapp Mt | 1 | 1 | Jun 2025 |
| Telmisartan Amlodipine Tabletsip | 1 | 1 | May 2025 |
| Telivi H Telmisartan Hydrochorothiazide | 1 | 1 | Apr 2025 |
| Telmivaz Telmisartan | 1 | 1 | Mar 2025 |
| Telso | 1 | 1 | Mar 2025 |
| Telvas | 1 | 1 | Mar 2025 |
| Telvas Am | 1 | 1 | Mar 2025 |
| Telvas H / | 1 | 1 | Mar 2025 |
| Telmisartan Hydrochloro Thiazide | 1 | 1 | Feb 2025 |
| Telmisartan Telmasil | 1 | 1 | Feb 2025 |
| Telma H Telmisartan Hydrochlorot Hiazide | 1 | 1 | Aug 2024 |
| Telmisartan Andamlodipine | 1 | 1 | May 2024 |
| Telmisartan Tables | 1 | 1 | Apr 2024 |
| Telgo | 1 | 1 | Dec 2023 |
| Telmisartan Chlorthalidone | 1 | 1 | Aug 2023 |
| Teripil | 1 | 1 | May 2023 |
| Telmirid | 1 | 1 | Mar 2023 |
| Telma | 1 | 1 | Feb 2023 |
| Loose | 1 | 0 | Jan 2023 |
| Telmistad | 1 | 1 | Dec 2022 |
| Telione | 1 | 1 | Mar 2022 |
| Telmopac Am Telmisartan Amlodipine | 1 | 1 | Nov 2021 |
Top 30 of 32 products by number of batches.
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Telmisartan Tablets IP 40mg | Batch 493TTF002Mfg Jul 2025 · Exp Jun 2027 | Swiss Garnier Life SciencesHimachal Pradesh | The Sample does not conform to IP standards with respect to the test Dissolution.Dissolution | RDTL , ErnakulamState lab | Sep 2026 |
| Telmisartan Tablets IP 40 mg | Batch CHPLT1346Mfg Feb 2026 · Exp Jan 2028 | Cureza Healthcare Pvt. LtdMadhya Pradesh | The sample does not conform to standard quality in respect to the test for ?Dissolution & Assay? performed.Assay | SDTL, Agartala, TripuraState lab | Sep 2026 |
| Telmisartan Tablets IP 40 mg | Batch TLB08B26CMfg Feb 2026 · Exp Jan 2028 | Bajaj Healthcare Ltd. R.S. No. 1818Gujarat | DESCRIPTION ? TABLETS HAVING BLACK SPOTS.Description | SDTL, UttarakhandState lab | Sep 2026 |
| Telmisartan And Metoprolol Succinate Extended Release Tablets (40 mg+50 mg) | Batch GLB26001Mfg Feb 2026 · Exp Jan 2028 | Glenmark Pharmaceuticals LtdMaharashtra | The sample does not conform to declared formula, in respect of content of TelmisartanOther | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Telmisartan 40 mg and Amlodipine 5 mg Tablets IP | Batch 18250527Mfg Oct 2025 · Exp Sep 2028 | Glenmark Pharmaceuticals LtdSikkim | The sample does not conform to IP in respect of Dissolution of TelmisartanDissolution | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Telmisartan & Amlodipine Tablets I.P. | Batch DLT-260356Mfg May 2026 · Exp Apr 2028 | Daffohills Laboratories Pvt. LtdUttarakhand | ASSAY OF AMLODIPINE BESYLATE I.P ? Less than prescribed limit.Assay | SDTL, UttarakhandState lab | Sep 2026 |
| Telmisartan Tablets IP 40 mg | Batch 493TTF024Mfg Aug 2025 · Exp Jul 2027 | Swiss Garnier Life SciencesHimachal Pradesh | The sample does not conform to IP standards with respect to the test DissolutionDissolution | RDTL, EKMState lab | Aug 2026 |
| Telmisartan Tablets IP 40 mg | Batch 493TTF026Mfg Nov 2025 · Exp Oct 2027 | Swiss Garnier Life SciencesHimachal Pradesh | The sample does not conform to IP standards with respect to the test Dissolution.Dissolution | RDTL, EKMState lab | Aug 2026 |
| Telmisartan Tablets IP 40 mg | Batch TM5145Mfg Sep 2025 · Exp Aug 2027 | Kerala State Drugs and Pharmaceuticals LtdKerala | The sample does not conform to IP standards with respect to Description.Description | DTL, ThrissurState lab | Aug 2026 |
| Telmisartan Tablets IP 40 mg | Batch TM 5139Mfg Sep 2025 · Exp Aug 2027 | Kerala State Drugs and Pharmaceuticals LtdKerala | The sample does not conform to IP standards with respect to Description.Description | DTL, ThrissurState lab | Aug 2026 |
| Telmisartan 40 mg tablets I.P. | Batch DEMT-250831BMfg Apr 2025 · Exp Mar 2027 | Dr. Edwin Medilabs Pvt.LtdPunjab | Sample Does not meets the Specifications wrt. Uniformity of weight as per IPUniformity of weight/content | State Lab, DCL, TelanganaState lab | Aug 2026 |
| Telmisartan 40 mg and Amlodipine 5mg tablets IP | Batch 18240554Mfg Jul 2024 · Exp Jun 2027 | Glenmark Pharmaceuticals LtdSikkim | Test For Assay (Content) Of TelmisartanAssay | DTL, DelhiState lab | Aug 2026 |
| Telmisartan & Amlodipine Tablets IP (Telsa A) | Batch GTF2327C,Mfg Oct 2025 · Exp Sep 2027 | Digital VisionHimachal Pradesh | The sample does not conforms to the IP with respect to Assay of Amlodipine Besilate Eq. to AmlodipineAssay | DTL, JaipurState lab | Aug 2026 |
| Telmisartan Tablets IP 40mg | Batch STS-114Mfg May 2025 · Exp Apr 2027 | Marc Lifesciences SikkimSikkim | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Telmisartan Tablets IP 40 mg | Batch 493TTF004Mfg Jul 2025 · Exp Jun 2027 | Swiss Garnier Life SciencesHimachal Pradesh | The sample does not conform to IP standards. If fails the test Dissolution as per IPDissolution | DTL, TVPMState lab | Jul 2026 |
Showing 15 of 213 records
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.